JG
IART icon

Jefferies Group’s Integra LifeSciences IART Stock Holding History

Jefferies Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-91,700
Closed -$4.95M – 1777
2022
Q2 		$4.95M Sell
91,700
-31,900
-26% -$1.92M 0.04% 354
2022
Q1 		$7.94M Buy
+123,600
New +$8.14M 0.05% 286

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jefferies Group's IART Position: Q3 2022 in Review

Jefferies Group increased its Integra LifeSciences (IART) stake by 124% in Q3 2022, buying an estimated $157K and bringing the position to 5,511 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Jefferies Group first reported a position in IART in Q3 2014 and has held it in 13 quarters since. The position peaked at $4.73M in Q1 2022. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

  • Jefferies Group held 5,511 shares of Integra LifeSciences worth $233K as of Q3 2022.
  • Jefferies Group bought 3,055 Integra LifeSciences shares in Q3 2022, an estimated $157K.
  • Integra LifeSciences made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1321 holding.
  • Jefferies Group first reported a position in Integra LifeSciences in Q3 2014 and has held it in 13 quarters since.
  • Jefferies Group's Integra LifeSciences position peaked at $4.73M in Q1 2022.
  • 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.